T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEVA
2476
Aeva Technologies
AEVA
$1.56B
| $347K | ﹤0.01% |
16,032
-8,705
| -35% | -$214K |
|
2477
Washington Trust Bancorp
WASH
$767M
| $345K | ﹤0.01% |
6,562
+277
| +4% | +$15.5K |
|
2478
Harmony Biosciences
HRMY
$2.24B
| $344K | ﹤0.01% |
7,065
+500
| +8% | +$20.4K |
|
2479
Mesa Laboratories
MLAB
$633M
| $344K | ﹤0.01% |
1,349
+112
| +9% | +$30.4K |
|
2480
StoneCo
STNE
$2.49B
| $344K | ﹤0.01% |
29,387
-5,297,290
| -99% | -$69.2M |
|
2481
Voyager Therapeutics
VYGR
$198M
| $344K | ﹤0.01% |
45,100
-45,800
| -50% | -$204K |
|
2482
Microvast
MVST
$341M
| $343K | ﹤0.01% |
51,200
+18,600
| +57% | +$121K |
|
|
PFC
2483
DELISTED
Premier Financial Corp. Common Stock
PFC
| $343K | ﹤0.01% |
11,310
+653
| +6% | +$20.1K |
|
|
SRDX
2484
DELISTED
Surmodics
SRDX
| $342K | ﹤0.01% |
7,540
-1,674
| -18% | -$73.3K |
|
2485
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
| $342K | ﹤0.01% |
1,500
-350
| -19% | -$78.7K |
|
|
BCOV
2486
DELISTED
Brightcove, Inc.
BCOV
| $342K | ﹤0.01% |
43,886
-280
| -0.6% | -$2.38K |
|
|
CBAY
2487
DELISTED
Cymabay Therapeutics
CBAY
| $342K | ﹤0.01% |
110,123
+13,472
| +14% | +$42.4K |
|
2488
Oric Pharmaceuticals
ORIC
$1.42B
| $340K | ﹤0.01% |
63,660
+15,891
| +33% | +$143K |
|
|
LBAI
2489
DELISTED
Lakeland Bancorp Inc
LBAI
| $340K | ﹤0.01% |
20,380
+9,267
| +83% | +$171K |
|
|
ICPT
2490
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $340K | ﹤0.01% |
20,891
-6,523
| -24% | -$102K |
|
2491
Liberty Latin America Class A
LILA
$1.67B
| $338K | ﹤0.01% |
51,277
+1,587
| +3% | +$11.4K |
|
2492
Commercial Vehicle Group
CVGI
$130M
| $336K | ﹤0.01% |
39,808
+877
| +2% | +$7.1K |
|
2493
Root
ROOT
$772M
| $336K | ﹤0.01% |
9,478
+3,111
| +49% | +$112K |
|
2494
Stagwell
STGW
$2.28B
| $336K | ﹤0.01% |
46,410
+17,300
| +59% | +$130K |
|
|
FRG
2495
DELISTED
Franchise Group, Inc.
FRG
| $336K | ﹤0.01% |
8,109
+591
| +8% | +$27.4K |
|
|
FSP
2496
Franklin Street Properties
FSP
$46.4M
| $335K | ﹤0.01% |
56,714
+2,195
| +4% | +$12.7K |
|
2497
Kinross Gold
KGC
$31.9B
| $335K | ﹤0.01% |
57,037
| – | – |
|
|
ATRS
2498
DELISTED
Antares Pharma, Inc.
ATRS
| $334K | ﹤0.01% |
81,560
+36,303
| +80% | +$132K |
|
2499
Energy Recovery
ERII
$399M
| $333K | ﹤0.01% |
16,530
+956
| +6% | +$18.6K |
|
2500
Rocket Companies
RKT
$42.6B
| $333K | ﹤0.01% |
29,965
+7,533
| +34% | +$93.2K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.